GeneticsLife Science AlliancePeer-reviewed
Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication
Tobias Moll, Valerie Odon, Calum Harvey…·Johnathan Cooper‐Knock
The paper identifies reduced EXOSC2 expression as protective against SARS-CoV-2 infection and clinical COVID-19 by inhibiting viral replication and upregulating antiviral genes.
4 citations